Norton Rose Fulbright
We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Norton Rose Fulbright advises a broad range of clients in the life sciences sector, including pharma and medical device companies, bioscience and biotech businesses, retail pharmacies, wholesale distributors, food tech companies, and investors such as venture capital and private equity firms. The firm focuses on litigation affecting participants across the sector, but also handles regulatory and commercial matters. D’Lesli Davis, head of life sciences and healthcare, serves as lead trial counsel for pharma and medical device clients in mass tort cases, including multidistrict litigation and consolidated proceedings in state and federal courts. Jonathan Skidmore, global co-head of life sciences and healthcare, focuses on matters involving pharma products, medical products, and device liability, with substantial experience representing clients in complex mass tort litigation. Both lawyers mentioned above are based in Dallas.
Legal 500 Editorial commentary
Key clients
- Alcon Inc.
- Sanctum Therapeutics Corporation
Work highlights
Advised Alcon Inc. in its merger agreement to acquire LENSAR, Inc.


